High-profile paper on FSHD published in Cell by Drs. Davide Gabellini and Daphne Cabianca in Milan, Italy. There are three distinct messages in the paper: 1. FSH Society funding leads to breakthroughs; 2. Junk DNA may be responsible for FSHD and other examples of faulty gene regulation; and 3. DBE-T may be a valid therapeutic target for FSHD More
Posted on: May 07, 2012
Leave a Reply